Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Gout Treatments Effective If Patients Maintain Lifelong Adherence to Therapies

Karen Appold  |  Issue: January 2017  |  January 19, 2017

Although gout is one of the most effectively treated of all rheumatic diseases, it is among the worst-managed diseases long term, as shown by many studies. “Treatments are excellent, yet are dramatically under-utilized,” says Theodore Fields, MD, FACP, rheumatologist, Hospital for Special Surgery (HSS), New York. “This is because some gout patients feel better between attacks and stop taking their medication, or they ignore or never fully assimilate the need for lifelong therapy.”

Further, they focus on alternative therapies, such as diet, as a way to relieve symptoms. “Diet alone is rarely sufficient [for patients] to reach remission,” Dr. Fields says. “Patients may feel guilty about not adhering to dietary guidelines and, therefore, avoid discussing self-induced flares with their physicians.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Concerns about the side effects of gout medications may also play a role in patients not sticking to medication regimens,” Dr. Fields continues. “When a patient starts taking a urate-lowering therapy (ULT), they may get mobilization flares, conclude the medication is not working and stop taking it—which is the wrong thing to do. Or because gout has been shown to have multiple co-morbidities, such as hypertension, kidney disease and diabetes mellitus, patients may decide they are taking too many pills and stop the gout-related medications.”

Working Together to Reduce Gout Flares

Suffering, loss of quality of life and loss of work time have been well documented as substantial for gout patients. There are more than 8.3 million gout patients; the great majority are presently followed by primary care physicians.1,2 Although rheumatologists don’t see all gout patients, Dr. Fields says they can play a major role in managing the most difficult gout patients and in educating primary care physicians about optimal gout management.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Rheumatologists can help gout patients by developing effective and ongoing strategies for patient education and monitoring so they truly understand why they are being asked to take on the burdens of urate monitoring, diet and lifestyle modification, and lifelong therapy,” Dr. Fields says. “Patients need ongoing reminders about why they need to stay on their ULT and follow up on their urate level to allow for appropriate dose titration.

“Every gout patient should know their uric acid level goal just as a diabetic knows their HbA1c goal or a hypertensive patient has a blood pressure goal,” he says. Rheumatologists should educate their primary care colleagues about the importance of closely monitoring gout patients, and referring them to a rheumatologist when a patient is having difficulty reaching a urate goal or managing refractory flares.

A Need for Education

Because successful gout management requires a complex regimen of medications and self-management involving medication adherence and dietary guidelines, it is essential that patients have a good understanding of how and why medications are used, and how diet affects attacks.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:ArthritisAssociation of Rheumatology Professionals (ARP)ClinicalGoutmaintenanceoutcomepatient careResearchtherapyTreatment

Related Articles

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

    Clinical Insights into Gout Management: Q&A with Dr. Tuhina Neogi

    February 9, 2022

    Gout affects more than 9.2 million adults in the U.S. and is the most common form of inflammatory arthritis. This condition and its complications are painful and potentially disabling with varying risk factors. It is characterized by symptoms that are usually sudden, with intense episodes of painful swelling in one or more joints, most often…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences